SCHEMBL41191

SCHEMBL41191

c1ccc(Cc2ccccn2)nc1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.59
HRH1 P35367 2/20 0.58
HRH3 Q9Y5N1 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.56
MAPT P10636 1/20 0.56
LIN28A Q9H9Z2 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
LMNA P02545 1/20 0.56
TAAR1 Q96RJ0 1/20 0.56
ALDH1A1 P00352 1/20 0.56
ALOX15 P16050 1/20 0.56
HRH4 Q9H3N8 1/20 0.55
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
ASIC3 Q9UHC3 1/20 0.52
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29830938 1.00 L3MBTL1 (0.59) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
SCHEMBL4938207 0.97 L3MBTL1 (0.57) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
Ammonia Solution, Strong SCHEMBL6176560 0.97 L3MBTL1 (0.57) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
SCHEMBL4938201 0.97 L3MBTL1 (0.57) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
Bromide SCHEMBL6114859 0.97 L3MBTL1 (0.57) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL10884973 0.97 L3MBTL1 (0.57) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
SCHEMBL29715188 0.97 L3MBTL1 (0.57) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
SCHEMBL7948124 0.90 HRH3 (0.55) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
SCHEMBL7948123 0.90 HRH3 (0.55) L3MBTL1HRH1HRH3SMN1; SMN2MAPT
Dipyridyl SCHEMBL4975687 0.90 KDM4E (0.67) L3MBTL1HRH1HRH3SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1693 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117004174-A Preparation method and application of modified hydroxyapatite/polyether-ether-ketone composite material 中山大学 2023-11-07 CN claimed
CN-115584142-B Cyanine dye with red luminous ring structure and synthesis method thereof 三峡大学 2023-07-11 CN claimed
CN-115584142-A Red luminous cyanine dye with ring structure and synthesis method thereof 三峡大学 2023-01-10 CN claimed
CN-114868268-A Perovskite semiconductor device 剑桥企业有限公司 2022-08-05 CN claimed
EP-3195708-A1 LEVELERS FOR COPPER DEPOSITION IN MICROELECTRONICS MACDERMID ENTHONE INC. (US) 2017-07-26 EP claimed
US-9493469-B2 Piperidine inhibitors of Janus kinase 3 AUSPEX PHARMACEUTICALS, INC. (US) 2016-11-15 US claimed
EP-2022803-B1 PROCESS FOR PRODUCING FUNCTIONALIZED POLYMERS BRIDGESTONE CORP (JP) 2016-09-14 EP claimed
US-9193902-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2015-11-24 US claimed
US-8981020-B2 Process for producing functionalized polymers BRIDGESTONE CORPORATION (JP) 2015-03-17 US claimed
US-8859533-B2 Metalloinsertor complexes targeted to DNA mismatches CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-10-14 US claimed
US-7195829-B2 Organic element for electroluminescent devices EASTMAN KODAK COMPANY (US) 2007-03-27 US claimed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP claimed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US claimed
US-6917159-B2 Microcavity OLED device EASTMAN KODAK COMPANY (US) 2005-07-12 US claimed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP claimed
WO-2005018011-A2 MICROCAVITY OLED DEVICE EASTMAN KODAK COMPANY (US) 2005-02-24 WO claimed
US-20050037232-A1 Microcavity oled device EASTMAN KODAK COMPANY 2005-02-17 US claimed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO claimed
EP-0707564-B1 DIFLUORO STATONE ANALOGS MERRELL PHARMA INC (US) 2000-09-20 EP claimed
CN-1102648-A Substituted mono- and bipyridylmethylpyridenes BAYER AG (DE) 1995-05-17 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 L3MBTL1 823/4885HRH1 4215/4885HRH3 4179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.